对抗阿尔茨海默病的保护性遗传变异
Claudia Marino1, Vincent Malotaux2, Averi Giudicessi3
1The Schepens Eye Research Institute of Mass Eye and Ear and the Department of Ophthalmology at Harvard Medical School, Boston, MA, USA; Department of Neurology, Sealy Institute for Drug Discovery and Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, Galveston, TX, USA.
The Lancet. Neurology
|May 23, 2025
概括
保护性遗传变异可以延迟阿尔茨海默病 (AD) 的认知衰退. 在具有主导突变的家族中研究这些变异为开发新的AD疗法提供了对弹性途径的洞察.
科学领域:
- 神经遗传学 神经遗传学
- 阿尔茨海默氏症疾病研究研究
- 认知性 认知性
背景情况:
- 遗传因素显著影响阿尔茨海默病 (AD) 的发展和进展.
- 已经确定了保护性遗传变异,可以在零星和自体主导的AD病例中延迟认知障碍的出现.
- 研究具有自体主导突变的家族提供了一个独特的模型,用于识别AD的遗传修饰者.
研究的目的:
- 为了研究保护性遗传变异,赋予抗阿尔茨海默病的弹性.
- 确定涉及认知性的生物途径,例如肝硫酸蛋白糖-APOE受体和TREM-2信号通路.
- 探索基于对AD的自然保护机制的治疗策略.
主要方法:
- 对偶发性和自体主导性阿尔茨海默病患者的遗传研究的分析.
- 在APOE和RELN等基因中识别和表征罕见的遗传变异.
- 研究与认知性和AD进展相关的生物途径.
主要成果:
- 发现了保护性遗传变异,延迟了AD的认知障碍.
- 关键途径的识别,包括肝硫酸蛋白糖-APOE受体途径和微质TREM-2信号传递,有助于认知性.
- 了解细胞酶在AD弹性中的作用.
结论:
- 基因洞察对于开发阿尔茨海默氏症疾病修饰疗法至关重要.
- 通过遗传研究发现的保护性途径的向提供了新的治疗途径.
- 复制自然遗传防御的有益影响可能会减缓或阻止AD的进展.
更多相关视频
相关概念视频
Human Genetics
746
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
746
Alzheimer's Disease: Overview
689
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
689
Genome-wide Association Studies-GWAS
14.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.4K
Alzheimer's Disease: Treatment
266
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
266
Genetic Lingo
105.1K
Overview
105.1K
Comparing Copy Number Variations and SNPs
18.0K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.0K


